BIOLASE, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Concentrations (Tables)

Concentrations (Tables)

12 Months Ended

Dec. 31, 2014

Risks And Uncertainties [Abstract]

Summary of Net Revenue from Various Products

Revenue from the Company’s products for the years ended December 31, 2014, 2013 and 2012 are as follows:

		Years Ended December 31,
		2014				2013				2012
Laser systems			61.9		%		68.6		%		73.8		%
Imaging systems			9.0		%		8.2		%		5.9		%
Consumables and other			13.7		%		11.5		%		10.4		%
Services			15.1		%		11.3		%		9.6		%
License fees and royalties			0.3		%		0.4		%		0.3		%
Total revenue			100.0		%		100.0		%		100.0		%

Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.

+ References + Details